World's Best Scientists 2026 revealed!
B. Mary E. von Blomberg

B. Mary E. von Blomberg

D-Index & Metrics

Immunology

D-Index
54
Citations
10522
World Ranking
3893
National Ranking
150

Best Publications

  • A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

    Giuseppe Giaccone;Cornelis J. A. Punt;Yoshitaka Ando;Rita Ruijter

  • Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease.

    G. Bouma;J. B. A. Crusius;M. Oudkerk Pool;J. J. Kolkman

  • Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

    Alfons J M van den Eertwegh;Jurjen Versluis;H Pieter van den Berg;Saskia J A M Santegoets

  • Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.

    Johan W Molling;Wendy Kölgen;Hans J J van der Vliet;Martijn F Boomsma

  • Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage.

    Hans J.J. van der Vliet;B.Mary E. von Blomberg;Nobusuke Nishi;Martine Reijm

  • Low Levels of Circulating Invariant Natural Killer T Cells Predict Poor Clinical Outcome in Patients With Head and Neck Squamous Cell Carcinoma

    Johan W. Molling;Jacqueline A. E. Langius;Johannes A. Langendijk;C. Rene Leemans

  • Reduced frequency of nickel allergy upon oral nickel contact at an early age.

    I. M. W. Hoogstraten;K. E. Andersen;B. M. E. Blomberg;D. Boden

  • Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells

    Abdulbaqi Al-toma;Otto J. Visser;Hyacintha M. van Roessel;B. Mary E. von Blomberg

  • Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.

    Hans J. J. van der Vliet;B. Mary E. von Blomberg;Mette D. Hazenberg;Nobusuke Nishi

  • In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans.

    E. J. Giltay;J. C. M. Fonk;B. M. E. von Blomberg;H. A. Drexhage

  • Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients

    J. B. A. G. Haanen;A. Baars;R. Gomez;P. Weder

  • Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.

    Wieke H.M. Verbeek;Marije S. Goerres;B. Mary E. von Blomberg;Joost J. Oudejans

  • Cladribine Therapy in Refractory Celiac Disease With Aberrant T Cells

    Abdulbaqi Al–toma;Marije S. Goerres;Jos W.R. Meijer;B. Mary E. von Blomberg

  • Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15

    Hans J.J van der Vliet;Nobusuke Nishi;Yasuhiko Koezuka;B.Mary E von Blomberg

  • The immunoregulatory role of CD1d-restricted natural killer T cells in disease

    Hans J J van der Vliet;Johan W Molling;B Mary E von Blomberg;Nobusuke Nishi

  • Human natural killer T cells acquire a memory-activated phenotype before birth

    Hans J. J. van der Vliet;Nobusuke Nishi;Tanja D. de Gruijl;B. Mary E. von Blomberg

  • Transition metal sensing by Toll-like receptor-4: next to nickel, cobalt and palladium are potent human dendritic cell stimulators

    Dessy Rachmawati;Hetty J. Bontkes;Marleen I. Verstege;Joris Muris

  • Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure

    S. W. Spiekstra;M. J. Toebak;S. Sampat‐Sardjoepersad;P. J. Van Beek

  • High frequency of celiac disease in Down syndrome

    Unknown

  • Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

    Famke L. Schneiders;Rik J. Scheper;B. Mary E. von Blomberg;Andrea M. Woltman

Frequent Co-Authors

Rik J. Scheper
Rik J. Scheper Amsterdam University Medical Centers
Chris J. J. Mulder
Chris J. J. Mulder Amsterdam UMC
Giuseppe Giaccone
Giuseppe Giaccone Cornell University
Marco W.J. Schreurs
Marco W.J. Schreurs Erasmus University Rotterdam
Tanja D. de Gruijl
Tanja D. de Gruijl Vrije Universiteit Amsterdam
Thomas Rustemeyer
Thomas Rustemeyer University of Amsterdam
Johannes A. Langendijk
Johannes A. Langendijk University Medical Center Groningen
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Georg Kraal
Georg Kraal Vrije Universiteit Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing B. Mary E. von Blomberg